
    
      In women at 26 to 30 weeks gestation, who are at increased risk for preterm birth and remain
      undelivered 14 or more days following a single course of antenatal corticosteroids (ACS), are
      multiple course of ACS every 14 days until 33 weeks effective in reducing the risk of
      perinatal or neonatal mortality or significant neonatal morbidity, compared to placebo.

      18-24 Month Follow-up: Children (18-24 months corrected gestational age) are assessed with
      the Bayley Scales of Infant Development (Second Edition) to determine neurodevelopmental
      impairment.

      5 Year Follow-up (MACS-5): Children are assessed using the Child Behaviour Checklist (1 1/2 -
      5) and the Behaviour Rating Inventory of Executive Function (Preschool version) to determine
      neurocognitive function.
    
  